Intelligence Market Report

+23% CAGR & COVID-19 Impact on Biobanking Market Can See 11.4 Billion by 2027 Major Qiagen N.V, Merck KGaA, VWR Corporation

According to figures from the National Cancer Center, about 9.5 million people were confirmed to have cancer in the U.S. in 2019, and this figure is projected to rise to 19 million in 2024.

 

London, UK -- (SBWIRE) -- 11/05/2021 -- Global Biobanking Market is valued approximately at USD 2.08 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 23.7% over the forecast period 2020-2027. Biobanking is a method for gathering and storing biological resources that can be further used for diagnostics, ecosystem studies, and analysis. Significant factors driving the growth of the global biobanking industry include expanded financial support from private and government organizations.

Book Your Sample Report As Per Your Business Requirement @ https://www.intelligencemarketreport.com/report-sample/41106

To provide an overview of the industry, the study looks at a number of significant categories and sub-segments. The report includes information on their financial projections, product portfolios, investment objectives, and business and marketing strategies, among other things. The research examines current and historical market conditions, as well as market development patterns, and forecasts that the market will rise in the coming years. The market research report examines the global Biobanking industry in-depth, providing information that will be useful to both newcomers and established businesses.

Major market players included in this report are:
Thermo Fisher Scientific Inc.
Panasonic Healthcare Holdings Co., Ltd.
Becton, Dickinson and Company
Qiagen N.V.
Merck KGaA
VWR Corporation
Tecan Trading AG
Brooks Automation, Inc.
Chart Industries, Inc.
Hamilton Company
Greiner Holding AG
Promega Corporation

The geographical analysis of the market is conducted on a worldwide and regional basis, with the results being used to assess the global market's performance throughout the forecast period. The global Biobanking market research analyses numerous key segments and sub-segments based on specification, application, end-users, and geography to provide an insight into the industry. In addition, the method enables the production of a market overview and forecast for each section of the region.

Ask For Customized Report As Per Your Business Requirement @ https://www.intelligencemarketreport.com/send-an-enquiry/41106

Market Segmentation
By Specimen Type:
Blood Products
Solid Tissue
Cell Lines
Nucleic Acid
Others

By Type of Biobank:
Population-based Biobanks
Disease-oriented Biobanks

By Application:
Therapeutic
Research

By Ownership:
National/Regional Agencies
Non-profit Organization
University
Private Organization

The Biobanking market research highlights the most significant acquisitions, collaborations, and product launches in the industry. To provide deeper insights into prominent players, the study report employs advanced research methods such as SWOT and Porter's Five Forces analysis. The research provides an overview of the worldwide competitive environment as well as key insights into the major competitors and their plans to expand their businesses. It also contains vital information on financial conditions, worldwide positioning, product portfolios, income, and gross profit margins, as well as technological and research advances.

Target Audience of the Global Biobanking Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Buy This Report Here @ https://www.intelligencemarketreport.com/checkout/41106

Contact Us:
Akash Anand
Head of Business Development & Strategy
sales@intelligencemarketreport.com
Phone: +44 20 8144 2758